SCHEMBL6540719

SCHEMBL6540719

O=C(O)NC1(CNCc2ccccc2)CCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.42
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 2/20 0.41
EPHX1 P07099 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
USP2 O75604 1/20 0.41
OPRM1 P35372 1/20 0.40
OPRL1 P41146 1/20 0.40
MAPK1 P28482 1/20 0.40
EPHX2 P34913 1/20 0.40
P2RX7 Q99572 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3618445 0.80 ADRB2 (0.65) ADRB2ALDH1A1HTTHDAC6MEN1
SCHEMBL3717417 0.78 ADRB2 (0.58) ADRB2ALDH1A1HTTSMN1; SMN2HDAC6
SCHEMBL7950503 0.77 CES1 (0.40) ALDH1A1HDAC8HDAC6MEN1KMT2A
SCHEMBL17065387 0.76 MEN1 (0.47) MEN1KMT2ATDP1
SCHEMBL6378630 0.75 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KMT2AHPGDEPHX1
SCHEMBL7277140 0.75 MEN1 (0.45) MEN1KMT2ATDP1HPGDEPHX1
Hydrochloric Acid SCHEMBL6378763 0.74 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2KMT2AHPGDEPHX1
SCHEMBL16839634 0.73 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL26126158 0.73 MEN1 (0.47) HDAC8HDAC6MEN1KMT2ATDP1
SCHEMBL19585998 0.72 MEN1 (0.50) ALDH1A1HDAC8HDAC6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6787543-B2 PREPARATION OF TACHYKININ ANTAGONISTS; SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-09-07 US disclosed
US-20030176430-A1 Benzhydryl derivatives ASTELLAS PHARMA INC. (JP) 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176430-A1 Benzhydryl derivatives BDKRB1, BDKRB2, TACR1 ADRB2 195/4885ALDH1A1 2029/4885HTT 668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.